Hims & Hers Health, Inc. Class A Common Stock is the equity of Hims & Hers Health, a consumer-focused digital health and telehealth platform. Hims & Hers connects customers with licensed healthcare professionals through its websites and mobile app, offering online consultations, prescriptions, laboratory testing, and follow-up support. Its current product and service lineup spans sexual health, hair care, mental health, weight loss, dermatology, and general wellness, with a mix of prescription and over-the-counter offerings. The company also provides personalized health solutions and fulfillment services through its branded consumer platform. Based in San Francisco and founded in 2017, Hims & Hers operates in the healthcare market as a direct-to-consumer service provider that combines clinical access, digital technology, and pharmacy-enabled delivery.
Omsætning og resultat (USD)
Gns. kursmål: $31,15
HIMS 5-DAY DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action
GlobeNewswire Inc. · 28. okt. 2026
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. · 27. okt. 2026
INV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV
GlobeNewswire Inc. · 25. okt. 2026
Hims & Hers Health, Inc. Class A Common Stock is the equity of Hims & Hers Health, a consumer-focused digital health and telehealth platform. Hims & Hers connects customers with licensed healthcare professionals through its websites and mobile app, offering online consultations, prescriptions, laboratory testing, and follow-up support. Its current product and service lineup spans sexual health, hair care, mental health, weight loss, dermatology, and general wellness, with a mix of prescription and over-the-counter offerings. The company also provides personalized health solutions and fulfillment services through its branded consumer platform. Based in San Francisco and founded in 2017, Hims & Hers operates in the healthcare market as a direct-to-consumer service provider that combines clinical access, digital technology, and pharmacy-enabled delivery.
Omsætning og resultat (USD)
Gns. kursmål: $31,15
HIMS 5-DAY DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action
GlobeNewswire Inc. · 28. okt. 2026
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc. · 27. okt. 2026
INV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV
GlobeNewswire Inc. · 25. okt. 2026